📚 PASS Research Analyst Certification Examination Difficulty: Beginner ℹ️ Info   ~5 min read
📌 Chapter 14.4 — Management of Conflicts of Interest and Disclosure Requirements for Research Analysts

Imagine you have just finished a deep-dive valuation model on a mid-cap IT services company. Your analysis suggests a significant upside, and your fingers are hovering over your brokerage app, tempted to accumulate shares before the report goes live. This is the precise moment Regulation 16 of the SEBI (Research Analysts) Regulations intervenes, acting as a structural barrier against the inherent temptation to front-run your own research.

Under this regulation, you are strictly prohibited from trading in the securities of a company that you are actively covering for a specific “quiet period” window.

This restriction mandates a thirty-day prohibition on personal trading before the publication of a research report and a five-day moratorium after its release. The logic here is centered on market integrity; if an analyst can trade ahead of a recommendation, they gain an unfair information advantage that undermines the public trust in the research process. By enforcing these time buffers, SEBI ensures that the analyst’s financial interests remain neutral, preventing the appearance—or reality—of market manipulation through proprietary trading strategies.

From a practitioner’s perspective, this means your personal portfolio must be secondary to your professional reporting obligations. You must treat your trading account with the same level of compliance scrutiny as your valuation models.

If you hold a pre-existing position in a company you are assigned to cover, Regulation 16 generally requires you to disclose this interest clearly within the report, or in many firm-internal policies, divest the position entirely to ensure that your “Buy” or “Sell” rating is not a vehicle to exit or enter a personal trade at a profit.

Consider the case of an analyst who observes a bullish trend in a sector but realizes their firm is about to initiate coverage on a laggard firm in that same space. If they traded on their sector knowledge, they would be in violation of the spirit of fair play. Regulation 16 effectively mandates a cold, clinical distance between the analyst as an investor and the analyst as a market commentator.

Compliance with these temporal constraints is not merely a box-ticking exercise; it is the fundamental safeguard that prevents the professional research ecosystem from being corrupted by the pursuit of private gains at the expense of retail investors.

Nuance

⚠️ Nuance
A common misconception among candidates is that Regulation 16 applies only to the analyst’s direct trades in the subject company. In reality, modern compliance frameworks extend this restriction to the analyst’s immediate family and accounts over which they have investment discretion. Candidates often fail to recognize that the 30-day pre-publication window is an absolute bar, regardless of whether the trade was based on ‘publicly available’ information, because the proximity to the report creation creates an irrebuttable presumption of conflict.

Check Your Understanding

Practice Question 1

An analyst completes a research report on a chemical manufacturer on October 1st, but due to internal review processes, the report is published on October 10th. When is the earliest the analyst can trade in the company’s shares?

Practice Question 2

Which of the following best describes the intent behind the 30-day pre-publication trading restriction for research analysts?

This is a companion read for Section 14.4 — Management of Conflicts of Interest and Disclosure Requirements for Research Analysts from PASS Research Analyst Certification Examination by Akhilesh Gururani, available on Amazon Kindle.

Copyright © 2026 Akhilesh Gururani. All rights reserved.